Dongguan Yunjing Optoelectronic Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Dongguan Yunjing Optoelectronic Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MISONVUE. The owner is based in Dongguan, Guangdong.
Rd., Nancheng St.,
Rm. 220, No. 11 Xiangyuan
Dongguan, Guangdong 523000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Dongguan Yunjing Optoelectronic Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Dongguan Yunjing Optoelectronic Technology Co., Ltd. have?
Dongguan Yunjing Optoelectronic Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Dongguan Yunjing Optoelectronic Technology Co., Ltd. file in?
Dongguan Yunjing Optoelectronic Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Dongguan Yunjing Optoelectronic Technology Co., Ltd.'s most well-known trademarks?
Dongguan Yunjing Optoelectronic Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as MISONVUE. These are among 1 currently registered trademark in the portfolio.
What is Dongguan Yunjing Optoelectronic Technology Co., Ltd.'s trademark registration success rate?
Dongguan Yunjing Optoelectronic Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.